leadXpro scientists chart the future of structure based drug discovery
leadXpro AG scientists explore the utility of cutting-edge X-ray technologies for the discovery of new therapeutics.
news
Latest developments, partnerships and scientific breakthroughs
leadXpro adopts creoptix’ wave technology for ligand characterization
Creoptix and leadXpro AG announce the selection of the Creoptix WAVE technology by leadXpro to strengthen its capabilities for drug discovery aimed at identifying and optimizing drug candidates directed against challenging membrane protein drug targets.
leadXpro and AXXAM collaborate on novel inflammatory GPCR target
leadXpro and AXXAM announce the collaboration for the discovery of small molecular ligands to a novel inflammation related GPCR target.
New Operational Space and Funding ensures further growth of LEADXPRO
Tripling its physical footprint and with a new funding round secured, leadXpro AG is well-prepared for further development.
GPCR-ligand complex structure within 4 months
In collaboration with a major pharma company, leadXpro AG announced today the successful delivery of multiple GPCR structure determination milestones ahead of schedule.
leadXpro enters collaboration on cryo-EM based new lead discovery with Bayer
leadXpro AG announced today a collaboration with Bayer AG to enable structure based drug discovery of membrane protein targets, facilitated by single particle cryo-Electron Microscopy (cryo-EM)
PARK INNOVAARE files building application for leadXpro’s future home
Park InnovAARE files building application for leadXpro’s future home
leadXpro and Boehringer Ingelheim collaborate on membrane protein drug target
leadXpro proudly reports a collaboration contract with Boehringer Ingelheim
leadXpro celebrates its first anniversary
LeadXpro takes its place as world leading structure based drug discovery company and celebrates its first anniversary
leadXpro and Paul Scherrer Institute sign agreement on Beam Line at the Swiss Light Source
Agreement with Paul Scherrer Institute on a beam line at the Swiss Light Source SLS